Kazuo Koshiji
Director of Finance/CFO bei SANTEN PHARMACEUTICAL CO., LTD.
Profil
Derzeit hat Kazuo Koshiji die Position des CFO, General Manager-Finance & Administration bei Santen Pharmaceutical Co., Ltd. inne. Er ist außerdem Mitglied des Vorstands von InnFocus, Inc. und Santen Holdings U.S., Inc.
Aktive Positionen von Kazuo Koshiji
| Unternehmen | Position | Beginn |
|---|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Director of Finance/CFO | - |
Santen Holdings U.S., Inc.
 Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Director/Board Member | - |
InnFocus, Inc.
 InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Director/Board Member | - |
Ehemalige bekannte Positionen von Kazuo Koshiji
| Unternehmen | Position | Ende |
|---|---|---|
Novagali Pharma SA
 Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Director/Board Member | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Health Technology |
Santen Holdings U.S., Inc.
Santen Holdings U.S., Inc. Financial ConglomeratesFinance Santen Holdings U.S., Inc. operates as holding company. The company is headquartered in Emeryville, CA. | Finance |
